Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | mRNA-2752 |
| Trade Name | |
| Synonyms | mRNA2752|mRNA 2752 |
| Drug Descriptions |
mRNA-2752 consists of an mRNA encoding OX40L, IL-23, and IL-36gamma encapsulated in a lipid nanoparticle, which may enhance antitumor immune response (Cancer Res (2024) 84 (6_Supplement): 6552). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C157247 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Durvalumab + mRNA-2752 | Durvalumab mRNA-2752 | 0 | 1 |
| mRNA-2752 | mRNA-2752 | 0 | 1 |
| mRNA-2752 + Tremelimumab | Tremelimumab mRNA-2752 | 0 | 1 |